Unfolding the role of protein misfolding in neurodegenerative diseases
The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurodegenerative diseases, such as AD and DLB, are often characterized as diseases of protein aggregation (30–33).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [30]
In the citing paper
“Importantly, most of these age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
In the citing paper
“The hallmark feature of these proteinopathies are the fibrillary aggregates of misfolded or hyperphosphorylated proteins (59).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
Background
Cited by
Items 601–700 of 1,001
Lemkul, J. A., Huang, J., & MacKerell, A. D. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b09978 · Cited by 32
Endoplasmic Reticulum Stress in Brain Damage
Raghubir, R., Nakka, V. P., & Mehta, S. L. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-385116-1.00015-7 · Cited by 32
Mishima, T., Ohkuri, T., Monji, A., Imoto, T., & Ueda, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.043 · Cited by 32
Nucleocytoplasmic transport inC9orf72-mediated ALS/FTD
Zhang, K., Grima, J. C., Rothstein, J. D., & Lloyd, T. E. (2016) · Nucleus · doi:10.1080/19491034.2016.1172152 · Cited by 37
“Protein aggregation is a pathological hallmark of neurodegenerative diseases including ALS/FTD, Alzheimer’s, Parkinson’s, and Huntington’s diseases.(18)”
BackgroundBiomaterials for Protein Delivery: Opportunities and Challenges to Clinical Translation
Gorantla, A., Hall, J., Troidle, A., & Janjic, J. M. (2024) · Micromachines · doi:10.3390/mi15040533 · Cited by 39
“The misfolded protein may turn into amorphous clots or aggregates with regular structures, each of which can lead to severe complications [14,15].”
BackgroundA same day α-synuclein RT-QuIC seed amplification assay for synucleinopathy biospecimens
Parveen, S., Alam, P., Orru, C. D., Vascellari, S., Hughson, A. G., Zou, W., Beach, T. G., Serrano, G. E., Goldstein, D. S., Ghetti, B. F., et al. (2025) · npj Biosensing · doi:10.1038/s44328-024-00023-w · Cited by 34
Insights into Mechanisms of Chronic Neurodegeneration
Diack, A. B., Alibhai, J. D., Barron, R. M., Bradford, B. M., Piccardo, P., & Manson, J. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010082 · Cited by 33
Vidoni, C., Castiglioni, A., Seca, C., Secomandi, E., Melone, M. A. B., & Isidoro, C. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.11.003 · Cited by 36
“Pathogenesis and progression of HD are strictly correlated with the presence in the affected neurons f cytoplasmatic aggregates and nuclear inclusions of the mutated form of the protein Hunting n (Htt) and of its N-terminal fragments (DiFiglia et al., 1997; Soto, 2003; Melone et al., 2005).”
BackgroundPace, M. C., Xu, G., Fromholt, S., Howard, J., Crosby, K., Giasson, B. I., Lewis, J., & Borchelt, D. R. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1895-y · Cited by 31
“Neurodegenerative disorders, including Alzheimer’s disease (AD), frontotemporal dementia (FTD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS) are characterized pathologically by the accumulation of misfolded proteins (often referred to as “proteinopathies”) [9, 21, 22, 41, 85, 86].”
Udovin, L., Quarracino, C., Herrera, M. I., Capani, F., Losada, M. E. O., & Perez‐Lloret, S. (2020) · Neural Plasticity · doi:10.1155/2020/1859431 · Cited by 32
“Abnormal accumulation of misfolded protein aggregates [4] as the Lewy bodies, made of α-synuclein [5], appears to be”
BackgroundTransmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates
Morales, R., Bravo-Alegria, J. B., Moreno‐González, I., Duran-Aniotz, C. A., Gamez, N., Edwards, G. A., & Soto, C. A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01150-w · Cited by 33
“Several proteins associated with neurodegenerative diseases, such as α-synuclein, tau, Aβ, among others, have been experimentally shown to share features with diseaseassociated prions [3, 17, 48].”
BackgroundSelf-citationWeiel, M., Götz, M., Klein, A., Coquelin, D., Floca, R. O., & Schug, A. H. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00366-3 · Cited by 31
Beam, M., Silva, M. C., & Morimoto, R. I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362764 · Cited by 34
“Protein misfolding and aggregation are implicated in a wide variety of diseases including Amyotrophic Lateral Sclerosis (ALS), at least nine CAG-repeat diseases, Alzheimer disease (AD), and Parkinson disease (PD) (1, 2).”
BackgroundThe Structural Impact of a Polyglutamine Tract Is Location-Dependent
Robertson, A. L., Horne, J., Ellisdon, A. M., Thomas, B., Scanlon, M. J., & Bottomley, S. (2008) · Biophysical Journal · doi:10.1529/biophysj.108.138487 · Cited by 31
Yan, L., Velkova, A., Tatarek‐Nossol, M., Andreetto, E., & Kapurniotu, A. (2007) · Angewandte Chemie · doi:10.1002/ange.200604056 · Cited by 31
Wu, A., Wong, V. K. W., Wu, J., Liu, L., & Law, B. Y. K. (2015) · Scientific Reports · doi:10.1038/srep17199 · Cited by 33
Translational opportunities for amyloid-targeting fluorophores
Cao, K., & Yang, J. (2018) · Chemical Communications · doi:10.1039/c8cc03619e · Cited by 36
Park, K.-W., Hahn, J., Fan, Q., Thiele, D. J., & Li, L. (2006) · Genetics · doi:10.1534/genetics.105.054221 · Cited by 32
Multiscale Surface Self-Assembly of an Amyloid-like Peptide
Lepère, M., Chevallard, C., Hernandez, J., Mitraki, A., & Guénoun, P. (2007) · Langmuir · doi:10.1021/la701042t · Cited by 32
Haldimann, P., Muriset, M., Vígh, L., & Goloubinoff, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234773 · Cited by 32
Moll, L., & Schubert, M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/384094 · Cited by 31
“Thus, alterations of insulin levels and insulin-mediated signals/transcription might be an interesting candidate to explain the association of obesity and dementia.”
BackgroundPopiel, H. A., Burke, J. R., Strittmatter, W. J., Oishi, S., Fujii, N., Takeuchi, T., Toda, T., Wada, K., & Nagai, Y. (2011) · Journal of Amino Acids · doi:10.4061/2011/265084 · Cited by 31
Onoda, A., Kawasaki, T., Tsukiyama∥, K., Takeda, K., & Umezawa, M. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00092 · Cited by 31
“There were no significant between-groups differences in the numbers or sex ratios of offspring litters at birth (Supplementary Table 1) or offspring body weights at 6 weeks of age (Supplementary Table 2).”
BackgroundDisruption of Placental Homeostasis Leads to Preeclampsia
Nakashima, A., Shima, T., Tsuda, S., Aoki, A., Kawaguchi, M., Yoneda, S., Yamaki‐Ushijima, A., Cheng, S., Sharma, S., & Saito, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093298 · Cited by 32
“Some of these aggregates are mediated by autophagy inhibition [15,56].”
BackgroundHalder, S., Aggrawal, R., Jana, S., & Saha, S. K. (2021) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2021.112351 · Cited by 30
Secondary Mechanisms of Neurotrauma: A Closer Look at the Evidence
Aghili-Mehrizi, S., Williams, E., Yan, S. C., Willman, M., Willman, J., & Lucke-Wold, B. P. (2022) · Diseases · doi:10.3390/diseases10020030 · Cited by 37
Doan, H. Q., Davis, A. C., & Francisco, J. S. (2010) · The Journal of Physical Chemistry A · doi:10.1021/jp100375c · Cited by 30
Pharmacotherapies for Parkinson’s disease symptoms related to cholinergic degeneration
Perez‐Lloret, S., Peralta, M. C., & Barrantes, F. J. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1254189 · Cited by 33
“abnormalities are the main factors leading to abnormal accumulation of misfolded protein aggregates [5].”
BackgroundYakubu, U. M., & Morano, K. A. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0209 · Cited by 30
Computational Study of the Driving Forces and Dynamics of Curcumin Binding to Amyloid-β Protofibrils
Martin, T. D., Malagodi, A. J., Chi, E. Y., & Evans, D. G. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b09185 · Cited by 31
Nature-inspired design and evolution of anti-amyloid antibodies
Julian, M. C., Rabia, L. A., Desai, A. A., Arsiwala, A., Gerson, J. E., Paulson, H. L., Kane, R. S., & Tessier, P. M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004731 · Cited by 31
“Protein aggregation is the seminal event in some of the most devastating neurodegenerative disorders (1,2).”
BackgroundMorales, R., Duran-Aniotz, C. A., Bravo-Alegria, J. B., Estrada, L. D., Shahnawaz, M., Hu, P., Kramm, C., Morales‐Scheihing, D., Urayama, A., & Soto, C. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01087-1 · Cited by 32
Self-citationElgersma, R. C., Rutters-Meijneke, T., de Jong, R., Brouwer, A. J., Posthuma, G., Rijkers, D. T. S., & Liskamp, R. M. J. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b606875h · Cited by 30
Potential common pathogenesis of several neurodegenerative diseases
Fan, T., Peng, J., Liang, H.-T., Chen, W.-Z., Wang, J.-L., & Xu, R.-S. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01054 · Cited by 20
“…fewer studies have reported on the roles of the adaptive immune system in HD. Inflammation may be stimulated by glial responses to neurodegeneration or by the immune cell activation that results from mHTT expression; in addition, these two pathways may exert synergistic effects in HD (Soto, 2003).”
InfluentialAmyloid‐β Aggregation with Gold Nanoparticles on Brain Lipid Bilayer
Lee, H., Kim, Y., Park, A., & Nam, J. (2014) · Small · doi:10.1002/smll.201303242 · Cited by 30
Higgins, R. K., Kabbaj, M.-H. M., Sherwin, D., Howell, L. A., Hatcher, A., Tomko, R. J., & Wang, Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107898 · Cited by 29
“The accumulation of misfolded proteins is associated with multiple neurodegenerative disorders, including Alzheimer’s and Huntington diseases (Knowles et al., 2014; Soto, 2003).”
A Comparative Photophysical Study of Structural Modifications of Thioflavin T‑Inspired Fluorophores
Needham, L.-M., Weber, J., Pearson, C. M., Do, D. T., Gorka, F., Lyu, G., Bohndiek, S. E., Snaddon, T. N., & Lee, S. F. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c01549 · Cited by 30
Martínez-Valbuena, I., Valenti‐Azcarate, R., Amat, I., Marcilla, I., Martí‐Andrés, G., Caballero, M. C., Riverol, M., Tuñon, M.-T., Fraser, P. E., & Luquín, M. R. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01171-0 · Cited by 32
Subcellular delivery of lipid nanoparticles to endoplasmic reticulum and mitochondria
Shi, Y., Luo, Z., & You, J. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1803 · Cited by 30
Kalita, S., Bergman, H., Dubey, K. D., & Shaik, S. S. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c12305 · Cited by 30
Inhibition of PKR protects against tunicamycin-induced apoptosis in neuroblastoma cells
Vaughn, L. S., Snee, B., & Patel, R. C. (2013) · Gene · doi:10.1016/j.gene.2013.11.074 · Cited by 30
“Several chronic neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's and Amyotrophic lateral sclerosis (ALS) exhibit abnormally folded proteins that aggregate and accumulate in neurons (Ross and Poirier, 2004; Soto, 2003).”
BackgroundPrion protein oligomer and its neurotoxicity
Huang, P., Lian, F., Wen, Y., Guo, C., & Lin, D. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt037 · Cited by 35
Nano-cage-mediated refolding of insulin by PEG-PE micelle
Fang, X., Yang, T., Wang, L., Yu, J., Wei, X., Zhou, Y., Wang, C., & Liang, W. P. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.007 · Cited by 30
Moll, L., Ben‐Gedalya, T., Reuveni, H., & Cohen, E. (2015) · The FASEB Journal · doi:10.1096/fj.15-281675 · Cited by 29
“Accordingly, the presence of aggregate deposits in the brain is a hallmark of these illnesses (8).”
BackgroundAdsorption Mechanism of Amyloid Fibrils to Graphene Nanosheets and Their Structural Destruction
Zhang, N., Hu, X., Guan, P., Zeng, K., & Cheng, Y. (2018) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.8b09893 · Cited by 29
Saha, P. C., Das, R. S., Chatterjee, T., Bhattacharyya, M., & Guha, S. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00153 · Cited by 31
Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases
Kabir, M. T., Uddin, M. S., Abdeen, A., Ashraf, G. M., Perveen, A., Hafeez, A., Bin-Jumah, M. N., & Abdel‐Daim, M. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200618114924 · Cited by 29
Study of Early Events in the Protein Folding of Villin Headpiece using Molecular Dynamics Simulation
Sonavane, U., Ramadugu, S. K., & Joshi, R. (2008) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2008.10507236 · Cited by 29
Ferreira, S. T., Felice, F. G. D., & Chapeaurouge, A. D. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:3:539 · Cited by 33
“As mentioned previously, considerable evidence supports the view that several important human pathologies, collectively known as amyloid diseases, share a common etiology related to protein misfolding, aggregation, and deposition in various organs (Table 1) ( 28 ).”
BackgroundInorganic Stressors of Ubiquitin
Arena, G., Bellia, F., Frasca, G., Grasso, G., Lanza, V., Rizzarelli, E., Tabbì, G., Zito, V., & Milardi, D. (2013) · Inorganic Chemistry · doi:10.1021/ic401276x · Cited by 28
Multistate Mechanism of Lysozyme Denaturation through Synchronous Analysis of Raman Spectra
Xing, L., Lin, K., Zhou, X., Liu, S., & Luo, Y. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b07900 · Cited by 28
Sang, J. C., Lee, J., Dear, A. J., De, S., Meisl, G., Thackray, A. M., Bujdoso, R., Knowles, T. P. J., & Klenerman, D. (2019) · Chemical Science · doi:10.1039/c8sc05627g · Cited by 28
Friend or foe: role of pathological tau in neuronal death
Wu, M., Chen, Z., Jiang, M. H., Bao, B., Li, D., Yin, X., Wang, X., Liu, D., & Zhu, L. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02024-z · Cited by 29
“Neurodegenerative diseases are often characterized by pathological protein formation, which in many cases is caused by protein misfolding and aggregation [9, 10].”
Chen, L., Zhang, J., Zhu, Y., & Zhang, Y. (2015) · RSC Advances · doi:10.1039/c5ra15301h · Cited by 28
Dysregulation of core components of SCF complex in poly-glutamine disorders
Bhutani, S., Das, A., Maheshwari, M., Lakhotia, S. C., & Jana, N. R. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.166 · Cited by 28
“Almost all neurodegenerative diseases, including polyQ diseases, are characterised by the presence of protein aggregates, which are believed to be toxic and cause neuronal death.(4)”
BackgroundWalsh, P. S., Dean, J. C., McBurney, C., Kang, H., Gellman, S. H., & Zwier, T. S. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp01062h · Cited by 28
Kinetics of Protein Aggregates Disposal by Aggrephagy
Tan, S., & Wong, E. S. P. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.09.084 · Cited by 31
Paul, S., & Paul, S. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b02727 · Cited by 29
Furr, J. W., Morales‐Scheihing, D., Manwani, B., Lee, J., & McCullough, L. D. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08568-0 · Cited by 29
“It has been described that changes in membrane permeability, intracellular calcium levels, mitochondria dysfunction, endoplasmic reticulum stress, and autophagy impairment, among others, could be the mechanisms by which misfolded proteins produce toxicity and cell death (Soto 2003).”
BackgroundHsp27 reduces glycation‐induced toxicity and aggregation of alpha‐synuclein
Miranda, H. V., Chegão, A., de Oliveira, M. S. D., Gomes, B. F., Enguita, F. J., & Outeiro, T. F. (2020) · The FASEB Journal · doi:10.1096/fj.201902936r · Cited by 30
Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases
Dash, R., Jahan, I., Ali, M. C., Mitra, S., Munni, Y. A., Timalsina, B., Hannan, M. A., & Moon, I. S. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105011 · Cited by 28
Bistability Explains Threshold Phenomena in Protein Aggregation both In Vitro and In Vivo
Rieger, T. R., Morimoto, R. I., & Vassily Hatzimanikatis, A. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.066662 · Cited by 28
“For neurons, this leads to a variety of neurodegenerative diseases including Parkinson’s, Huntington’s, Alzheimer’s, ALS, Scrapie, and others (4).”
BackgroundNeuroprotective effects of flavonoids: endoplasmic reticulum as the target
Amiri, B., Tabrizi, M. Y., Naziri, M., Moradi, F., Arzaghi, M., Archin, I., Behaein, F., Pour, A. B., Ghannadikhosh, P., Imanparvar, S., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1348151 · Cited by 31
“Pathological protein synthesis and, in many circumstances, the creation of high-order aggregates are frequently associated with neurodegenerative disease traits (Soto, 2003; Blokhuis et al., 2013; Michel et al., 2016).”
BackgroundA seeded propagation of Cu, Zn-superoxide dismutase aggregates in amyotrophic lateral sclerosis
Ogawa, M., & Furukawa, Y. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00083 · Cited by 28
“Among those, neurodegenerative diseases have been well characterized by abnormal accumulation of “mis”-folded proteins in brains and spinal cords of patients (Soto, 2003; Ross and Poirier, 2004).”
Zhang, X., Sun, X., Xue, D., Liu, D., Hu, X.-Y., Zhao, M., Yang, S., Yang, Y., Xia, Y., Wang, Y., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.09.005 · Cited by 30
Oura, M., Yamamoto, J., Ishikawa, H., Mikuni, S., Fukushima, R., & Kinjo, M. (2016) · Scientific Reports · doi:10.1038/srep31091 · Cited by 27
“In its initial aggregation process, it was pointed out that the orientation of ordered aggregates presumably has an important role in their toxicity and dynamics 21 .”
Briffa, M., Ghio, S., Neuner, J., Gauci, A. J., Cacciottolo, R., Marchal, C., Caruana, M., Cullin, C., Vassallo, N., & Cauchi, R. J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.058 · Cited by 29
Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases
Espargaró, A., Pont, C., Gámez, P., Muñoz‐Torrero, D., & Sabaté, R. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00398 · Cited by 27
Direct evidence of cellular transformation by prion-like p53 amyloid infection
Navalkar, A., Pandey, S., Singh, N., Patel, K., Datta, D., Mohanty, B. S., Jadhav, S. H., Chaudhari, P. R., & Maji, S. K. (2021) · Journal of Cell Science · doi:10.1242/jcs.258316 · Cited by 29
Secondary Structure Dependent Self‐Assembly of β‐Peptides into Nanosized Fibrils and Membranes
Martinek, T. A., Hetényi, A., Fülöp, L., Mándity, I. M., Tóth, G. K., Dékány, I., & Fülöp, F. (2006) · Angewandte Chemie · doi:10.1002/ange.200504158 · Cited by 27
Wang, J., Zhao, D., Pan, B., Fu, Y., Shi, F., Kouadir, M., Yang, L., Yin, X., & Zhou, X. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0442-0 · Cited by 27
“Some hypotheses have been proposed to interpret pathogenesis of prion disease, which include PrPSc gain-of-toxic function, PrPSc loss-of-function, chronic inflammation, activation of apoptotic or autophagy death pathways, and endoplasmic reticulum stress, induced by proteins misfolding and neuronal damage (Soto 2003).”
BackgroundNascimento, C. F., Nunes, P. V., Rodriguez, R. D., Takada, L. T., Suemoto, C. K., Grinberg, L. T., Nitríni, R., & Lafer, B. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.04.008 · Cited by 30
“which cell type, cellular compartments (intracellularly or extracellularly) or brain region (Soto, 2003; Soto and Estrada, 2008).”
BackgroundCobalt-based metal complexes prevent Repeat Tau aggregation and nontoxic to neuronal cells
Gorantla, N. V., Balaraman, E., & Chinnathambi, S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.278 · Cited by 26
An Update on Autophagy in Prion Diseases
López-Pérez, Ó., Badiola, J. J., Bolea, R., Ferrer, I., Llorens, F., & Martín‐Burriel, I. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00975 · Cited by 31
“Hence, prion diseases share profound similarities with other neurodegenerative disorders associated with the accumulation of misfolded protein aggregates like Alzheimer’s disease, Parkinson’s disease and Huntington’s disease (Soto, 2003).”
BackgroundZhang, Y., Zhang, M., Liu, Y., Zhang, D., Tang, Y., Ren, B., & Zheng, J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02958k · Cited by 26
Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer’s Disease
Kabir, E. R., Chowdhury, N. M., Yasmin, H., Kabir, M. T., Akter, R., Perveen, A., Ashraf, G. M., Akter, S., Rahman, M. H., & Sweilam, S. H. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666221010113812 · Cited by 26
“Aβ exerts various neurotoxic effects, including OS, the generation of ion channels and membrane disruptions, employment of various cellular factors, or activation of multiple cellular mechanisms, including inflammation and apoptosis [79-81].”
BackgroundMulti-Faceted Roles of DNAJB Protein in Cancer Metastasis and Clinical Implications
Kim, H.-Y., & Hong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314970 · Cited by 33
Im, D., Kim, S., Yoon, G., Hyun, D. G., Eom, Y., Lee, Y. E., Sohn, C. H., Choi, J., & Kim, H. I. (2023) · JACS Au · doi:10.1021/jacsau.2c00668 · Cited by 26
Condron, M. M., Monien, B. H., & Bitan, G. (2008) · The Open Biotechnology Journal · doi:10.2174/1874070700802010087 · Cited by 28
“Following this rationale, a large body of work has focused on peptides derived from the central hydrophobic cluster (A (17-21)) [41, 42], which had been shown to be important for A fibrillogenesis [43], though not necessarily for the formation of early oligomers.”
BackgroundZhu, S., Abounit, S., Korth, C., & Zurzolo, C. (2017) · Open Biology · doi:10.1098/rsob.160328 · Cited by 26
Ionic liquids as promoters of fast lysozyme fibrillation
Silva, N. H. C. S., Pinto, R. J. B., Martins, M. A., Ferreira, R. M., Correia, I., Freire, C. S. R., & Marrucho, I. M. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.08.064 · Cited by 26
Manipulating the Folding Landscape of a Multidomain Protein
Kantaev, R., Riven, I., Goldenzweig, A., Barak, Y., Dym, O., Peleg, Y., Albeck, S., Fleishman, S. J., & Haran, G. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b04834 · Cited by 26
Perrin, F. E., Boisset, G., Lathuilière, A., & Kato, A. C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04024.x · Cited by 32
“…a hallmark of several neurodegenerative disorders, might either participate in the neurodegenerative process or result from it; they could also be neuroprotective by sequestering toxic proteins (for reviews see Caughey and Lansbury 2003; Soto 2003; Bruijn et al. 2004; Ardley et al. 2005).”
BackgroundAcetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process
Pera, M., Martínez‐Otero, A., Colombo, L., Salmona, M., Ruiz‐Molina, D., Badía, A., & Clos, M. V. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.10.008 · Cited by 29
Aggresomes do not represent a general cellular response to protein misfolding in mammalian cells
Beaudoin, S., Goggin, K., Bissonnette, C., Grenier, C., & Roucou, X. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-59 · Cited by 26
“Neurodegenerative diseases include Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and related polyglutamine disorders, amyotrophic lateral sclerosis (ALS), and prion diseases, [1-3].”
BackgroundInhibition of Amyloid Fibril Formation by Peptide Analogues Modified with α‐Aminoisobutyric Acid
Gilead, S., & Gazit, E. (2004) · Angewandte Chemie · doi:10.1002/ange.200353565 · Cited by 26
Clarke, G. D., & Lumsden, C. J. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2004.10.028 · Cited by 26
Lin, H., Zhai, J., Cañete-Soler, R., & Schlaepfer, W. W. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5689-03.2004 · Cited by 27
“…(Hardy and Selkoe, 2002; Kirkitadze et al., 2002; Taylor et al., 2002; Berke and Paulson, 2003; Caughey and Lansbury, 2003; Ross et al., 2003; Soto, 2003) and that neurotoxic effects arise during early stages of protein aggregation before formation of highly insoluble fibrillary forms…”
BackgroundSen, N., Anishchenko, I., Bordin, N., Sillitoe, I., Velankar, S., Baker, D., & Orengo, C. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac187 · Cited by 25
“Some missense mutations can hence lead to changes in the structure of the protein [13, 14], which make the protein non-functional.”
Terahertz Metal-Graphene Hybrid Metamaterial for Monitoring Aggregation of Aß16-22 Peptides
Xu, L., Xu, J., Liu, W., Lin, D., Lei, J., Zhou, B., Shen, Y., & Deng, X. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132016 · Cited by 25
Rosa, F. L., Zoia, C., Bazzini, C., Bolognini, A., Saresella, M., Conti, E., Ferrarese, C., Piancone, F., Marventano, I., Fenoglio, C., et al. (2022) · Cells · doi:10.3390/cells11142180 · Cited by 25
The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice
Espina, M., Franco, N. D., Brañas-Navarro, M., Rodríguez-Navarro, I., Brito, V., López-Molina, L., Costas‐Insua, C., Guzmán, M., & Ginés, S. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106225 · Cited by 30
“However, most share an archetypical pathological attribute: aberrant aggregation of misfolded proteins that eventually triggers endoplasmic reticulum (ER) stress (Aguzzi and O'Connor, 2010; Bertram and Tanzi, 2005; Soto, 2003).”
BackgroundFurukawa, Y., & Nukina, N. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.011 · Cited by 28
“Many excellent reviews have been available on structural and biochemical properties of amyloids of those pathological proteins [5,6,11,23,24], and we will hence”
BackgroundKinetics of Surfactant-induced Aggregation of Lysozyme Studied by Fluorescence Spectroscopy
Jain, N., Bhattacharya, M., & Mukhopadhyay, S. (2010) · Journal of Fluorescence · doi:10.1007/s10895-010-0749-3 · Cited by 25
Brain aging and late-onset Alzheimer's disease: many open questions
Behl, C. (2012) · International Psychogeriatrics · doi:10.1017/s104161021200052x · Cited by 27
“In addition to changes in Aβ and tau in the hippocampi of patients with AD, disturbances of protein homeostasis resulting in protein aggregation also occurs in Parkinson’s disease (for instance, with disturbance of α-synuclein creating Lewy bodies), in Huntington’s disease (with disturbance of huntingtin in the striat…”
BackgroundBiswas, A., Kurkute, P., Jana, B., Laskar, A., & Ghosh, S. (2014) · Chemical Communications · doi:10.1039/c3cc49396b · Cited by 25
Châari, A., Eliezer, D., & Ladjimi, M. M. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.10.089 · Cited by 25
Oropesa‐Nuñez, R., Seghezza, S., Dante, S., Diaspro, A., Cascella, R., Cecchi, C., Stefani, M., Chiti, F., & Canale, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10449 · Cited by 25
“The aberrant self-assembly of peptide/protein molecules in the intra/extracellular space of tissues and organs to form highly structured fibrillar aggregates is associated with a group of highly debilitating pathological conditions including Alzheimer’s and Parkinson’s disease, familial amyloid polyneuropathy, spongif…”
BackgroundApplications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders
Im, W., Moon, J., & Kim, M. (2016) · Journal of Movement Disorders · doi:10.14802/jmd.16029 · Cited by 32
Pinto, C., Medinas, D. B., Fuentes‐Villalobos, F., Maripillán, J., Castro, A. F., Martínez, A. D., Osses, N., Hetz, C. A., & Henríquez, J. P. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104497 · Cited by 27
Metadata
- Authors
- Soto, C.
- Corresponding author
- Soto, Claudio
- ORCID
- Soto, Claudio
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 49-60
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2007157911
- Cited by
- 1,506
- References
- 154
- Citations by year
- 2026: 45 · 2025: 70 · 2024: 75 · 2023: 73 · 2022: 95 · 2021: 88 · 2020: 107 · 2019: 80 · 2018: 86 · 2017: 107 · 2016: 92 · 2015: 75 · 2014: 67 · 2013: 45 · 2012: 57
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- protein misfolding, neurodegenerative diseases, protein aggregation, protein accumulation, neuronal apoptosis, common pathogenic mechanisms, therapeutic target
- MeSH terms
- Animals, Brain, Brain Chemistry, Humans, Protein Folding, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.